| Previous Close | 2.69 |
| Open | 2.69 |
| Bid | 1.25 x 100 |
| Ask | 3.20 x 200 |
| Day's Range | 2.65 - 2.96 |
| 52 Week Range | 2.50 - 8.12 |
| Volume | 170,756 |
| Avg. Volume | 200,320 |
| Market Cap | 86.28M |
| Beta | N/A |
| PE Ratio (TTM) | -1.39 |
| EPS (TTM) | -2.03 |
| Earnings Date | Aug 3, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.00 |
- GlobeNewswire•5 days ago
T2 Biosystems Announces 2017 Second Quarter Financial and Operational Results Release and Conference Call Date
LEXINGTON, Mass., July 20, 2017-- T2 Biosystems, Inc. an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that it will release its 2017 second ...
- GlobeNewswire•7 days ago
T2 BIOSYSTEMS RECEIVES CE MARK FOR T2BACTERIA™ PANEL ENABLING COMMERCIALIZATION IN EUROPE
LEXINGTON, Mass., July 18, 2017-- T2 Biosystems, Inc., an emerging leader in the development of innovative diagnostic products to improve patient health, announced today that it has received a CE Mark ...
- Capital Cube•12 days ago
ETFs with exposure to T2 Biosystems, Inc. : July 13, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to T2 Biosystems, Inc. Here are 5 ETFs with the largest exposure to TTOO-US. Comparing the performance and risk of T2 Biosystems, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
